Industry: Pharmaceuticals, Biotechnology
geneRx+ is a privately held company focused on the creation and clinical testing of novel strategies for delivering proteins to inaccessible spaces. The Alphagen and Coxagen products epitomize the use of plasmid-liposome (lipoplex) formulations delivered to the lungs by aerosol in repeated doses to treat acquired lung diseases. The company is also developing novel protein formulations and delivery systems that target a broad range of pulmonary and cardiovascular diseases. ( www.generxplus.com )
geneRx+ Inc
3200 West End Avenue Suite 500
Nashville, Tennessee 37203
USA
Tel: (615) 783-2165
Fax: (615) 783-1606